Modeling, unraveling, and beating acquired resistance to BCMA and GPRC5D targeted agents in multiple myeloma

Basic Information

Funding Cycle : 2024-2025
Name : Jose A. Martinez-Climent
Type of Award : Translational Research Award
Home Institution : University of Navarra, Pamplona, Spain


In the current proposal we will use our recently developed mouse models of MM (Larrayoz et al, Nature Medicine 2023) carrying a new set of humanized therapeutic targets (BCMA and GPRC5D in MM cells and CD3 in T cells), with the aim of testing bi-specific antibodies in clinical use that otherwise cannot be tested against mouse cells. In these models we are reproducing the process of acquired refractoriness to BCMAxCD3 and GPRC5D agents, drugs that represent a breakthrough in MM therapeutics. However, despite encouraging data in clinical trials, most patients develop resistance and relapse. Therefore, we need to define the mechanistic basis of such therapeutic refractoriness and discover novel approaches to by-pass and defeat the acquired resistant state. This is the major goal of the current proposal. We envisage that our integrative approach using high-throughput RNA and DNA technologies at single-cell level in tumor and BM immune cells in both experimental and clinical samples will provide unprecedented results in field of MM acquired resistance to BCMA and GPRC5D targeted therapies. We expect that the proof-of-concept data generated will establish the scientific rationale to translating novel therapeutics overcoming the refractory state to the next clinical trials, which may eventually lead to the cure of MM.

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events